In a qualitative study of physicians managing patients with primary hyperoxaluria type 1 (PH1), presented at Kidney Week 2025, clinicians emphasized simplicity, patient convenience, and ease of...
In a large real-world cohort study comparing semaglutide with metformin, investigators found no significant difference in the risk of incident urinary stone disease. Despite meaningful reductions in BMI...
A new longitudinal study published in the Journal of the American Academy of Dermatology evaluated more than a decade of data from adults living with HIV, revealing a steady decline in dermatologic disease...
In this episode of Ask the Experts, dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares what's unique about the formulations of ZORYVE® (roflumilast). Mr. DiRuggiero discusses how...
In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with diabetes...
In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...
Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...
A 29-year-old woman with systemic lupus erythematosus (SLE) and a history of hypertension presented to the emergency department with acute chest pain and lower extremity paresthesia.
A 56-year-old Black man presented at the dermatology clinic with patchy scalp hair loss that began 4 months after receiving his second COVID-19 vaccination. The patient’s past medical history was remarkable...
Alexander O'Hara, MD; Daniel Sweeney, MD; Kirk Cahill, MD; Gail Kellberg, APN; Patrick Stiff, MD
A 28-year-old woman with HbSS sickle cell disease, bilateral avascular necrosis of the hips, and asthma initially presented to the emergency department with facial swelling and urticaria on her arms and...
A 67-year-old woman presented to the otolaryngologist’s office with a 2-week history of recurrent epistaxis and nasal airway obstruction limited to the right nasal passage.
Advanced or recurrent endometrial cancer has long meant limited paths forward. But that may be changing. In this short video, two experts share compelling phase 3 data on a treatment option and what it could mean for real-world care.
